Company: ELV
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001156039-25-000046
Chunk: 28

Company: Elevance Health, Inc.
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 28
---
                                                                                                           
 •Hold our Annual Meeting of Shareholders                                                                                                                                      |     | •Review voting results of our most recent Annual Meeting of Shareholders                         
 •Evaluate proxy season trends, corporate governance leading practices and peer company practices |     |                                                                                                                                                                                |     |                                |
| Winter                                                                                                                                                                        |     |                                                                                                  |     |                                                                                                                                                                                |     | Fall                           |
| •The Board uses feedback from our engagement meetings in its review of governance and compensation practices for the coming year                                              
 •Begin drafting the Proxy Statement and consider disclosure improvements based on engagement feedback                                                                         |     |                                                                                                  |     | •Active outreach with our largest shareholders to discuss corporate governance, executive compensation, strategy, environmental and social matters and other items of interest 
 •Shareholder feedback is shared with the Board and Board committees                                                                                                            |     |                                |
| Year-Round                                                                                                                                                                    |     |                                                                                                  |     |                                                                                                                                                                                |     |                                |
| •Regular meetings and calls with shareholders to discuss our strategic plan, consolidated business results and capital structure and other topics of interest to shareholders |     |                                                                                                  |     |                                                                                                                                                                                |     | •Quarterly earnings calls      
 •Numerous investor conferences 
 •Biennial investor day         |

We were pleased that our shareholders overwhelmingly approved the non-binding advisory vote on our executive compensation in 2024, with approximately 92% of votes cast voted in favor of the proposal. Nevertheless, we continue to examine our executive compensation program to ensure alignment between the interests of our executive officers and our shareholders.

#### Communications with the Board
Anyone wishing to communicate with the Board may do so:

• by email to boardofdirectors@elevancehealth.com ; or

• by letter addressed to our Corporate Secretary at Elevance Health, 220 Virginia Avenue, Indianapolis, Indiana 46204 .

If your message is directed towards non-management directors or a specific director, please address it to the attention of the Chair of the Board at either of the above addresses. Our independent directors have established an approved process for handling communications. Depending on the content and context of your message, it will be distributed to the entire Board or to specific directors. Communications that are unrelated to the duties and responsibilities of the Board such as mass mailings, medical claims inquiries, job inquiries, surveys, business solicitations or advertisements are not distributed. In addition, material that is unduly hostile, threatening, illegal or similarly unsuitable is excluded, but any such unsuitable communication is made available to any director upon request.

| 30 |

#### Corporate Governance